Case-Based Discussion of AUA Non-muscle Invasive Bladder Cancer Guidelines
CME Available: [ Ссылка ]
Course Director: Sam S. Chang, MD
Course Faculty: Christopher Anderson, MD; James Michael McKiernan, MD; Chad R. Ritch, MD; Kristen R. Scarpato, MD
Upon completion of this activity, participants will be able to:
1. Describe the evaluation and appropriate surveillance of patients with bladder cancer;
2. Determine the clinical risk of patients and apply appropriate therapeutic interventions;
3. Formulate multidisciplinary options for patients with invasive cancer;
4. Apply evidence-based and guidelines-based actions to complex clinical scenarios.
This educational activity is supported by independent educational grants from:
Astellas
AstraZeneca
Bristol-Myers Squibb
Genentech
Merck
Pfizer, Inc.
Sanofi Genzyme
